Comparison of gastrointestinal ultrasound with clinical activity and fecal calprotectin level in the assessment of disease activity in patients with inflammatory bowel disease

被引：0
|
作者：
Smith, R. [1 ,2 ]
Taylor, K. [1 ,2 ]
Friedman, A. [1 ,2 ]
Gibson, P. [1 ,2 ]
机构：
[1] Alfred Hlth, Melbourne, Vic, Australia
[2] Monash Univ, Melbourne, Vic, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
86
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [21] ASSOCIATION OF FECAL CALPROTECTIN WITH ENDOSCOPIC AND HISTOLOGY ACTIVITY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
    Crawford, Erin
    Gestrich, Catherine
    Malay, Sindhoosha
    Sferra, Thomas
    Saab, Shahrazad
    Moses, Jonathan
    GASTROENTEROLOGY, 2020, 158 (03) : S27 - S27
  • [22] Fecal lysozyme in assessment of disease activity in inflammatory bowel disease
    Veer, AV
    Brouwer, J
    Biemond, I
    Bohbouth, GE
    Verspaget, HW
    Lamers, CBHW
    DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (03) : 590 - 595
  • [23] Fecal Lysozyme in Assessment of Disease Activity in Inflammatory Bowel Disease
    Annet Van Der Sluys Veer
    Johan Brouwer
    Izak Biemond
    Graciela E. Bohbouth
    Hein W. Verspaget
    Cornelis B. H. W. Lamers
    Digestive Diseases and Sciences, 1998, 43 : 590 - 595
  • [24] Interrater reliability of the assessment of disease activity by gastrointestinal ultrasound in a prospective cohort of patients with inflammatory bowel disease
    Smith, Rebecca L.
    Taylor, Kirstin M.
    Friedman, Antony B.
    Su, Heidi Y.
    Con, Danny
    Gibson, Peter R.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (10) : 1280 - 1287
  • [25] Clinical utility of fecal calprotectin in monitoring disease activity and predicting relapse in pregnant patients with inflammatory bowel diseases
    Amihai, R.
    Mishael, T.
    Grisaru-Granovski, S.
    Koslowsky, B.
    Abitbol, G.
    Goldin, E.
    Shitrit, A. Bar-Gil
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S215 - S216
  • [26] Clinical utility of fecal calprotectin in monitoring disease activity and in with bowel diseases
    Rottenstreich, Amihai
    Mishael, Tali
    Granovsky, Sorina Grisaru
    Koslowsky, Benjamin
    Schweistein, Hagai
    Abitbol, Guila
    Goldin, Eran
    Shitrit, Ariella Bar-Gil
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 77 : 105 - 110
  • [27] Fecal calprotectin in inflammatory bowel disease
    Walsham, Natalie E.
    Sherwood, Roy A.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2016, 9 : 21 - 29
  • [28] Fecal calprotectin correlates with inflammatory disease activity as seen on CT imaging of the small bowel better than clinical assessment
    Rosenfeld, G.
    Brown, J.
    Vos, P.
    Leipsic, J.
    Enns, R.
    Bressler, B.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S149 - S149
  • [29] Gastrointestinal ultrasound in routine inflammatory bowel disease care: Accuracy compared with colonoscopy and fecal calprotectin
    Sathananthan, D.
    Rajagopalan, A.
    Van De Ven, L.
    Fon, J.
    Costello, S. P.
    Bryant, R. V.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 112 - 112
  • [30] HIGH CORRELATION BETWEEN FECAL IMMUNOCHEMICAL TEST AND FECAL CALPROTECTIN IN THE EVALUATION OF ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Torres-Diaz, Juan A.
    Yamamoto-Furusho, Jesus K.
    GASTROENTEROLOGY, 2023, 164 (06) : S898 - S899
12345